“…Among them, 1,2,4‐trioxanes have been attracting considerable interest of researchers in the fields of medicinal chemistry and pharmacology since the 1,2,4‐trioxane structural motif was found to be the core structure in artemisinin – the active pharmacophore against both chloroquinine‐sensitive and chloroquinine‐resistant malaria (Figure ) . Due to the fascinating biological activities of these structural compounds, some synthetic methods have been developed to construct 1,2,4‐trioxanes, for example, (i) rearrangements of ketodioxetanes, (ii) photochemical reaction of β‐ionone derivatives in the presence of oxygen, (iii) the reaction of endoperoxides with cyclohexanones, (iv) the photooxidation of enol ethers with oxygen followed by rearrangement of the resulting 1,2‐dioxetanes in the presence of trialkylsilyl triflates, (iv) the photo‐oxygenation of dihydropyrans, and (v) the condensation of β‐hydroxy hydroperoxides with carbonyl compounds in the presence of acid catalysts such as hydrochloric acid, p ‐toluenesulfonic acid ( p ‐TSA), 10‐camphorsulfonic acid (CSA), pyridinium p ‐toluenesulfonate (PPTS) and boron trifluoride . However, some of these synthetic methods suffer from certain constraints such as use of large amounts of strong acid, unsatisfactory yields, long reaction times, poorly accessible starting materials or narrow substrate scope, and this limits the application of these methods for large‐scale synthesis for 1,2,4‐trioxanes.…”